Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - STOCK-BASED COMPENSATION
Stock-based Compensation RPRX - Royalty Pharma plc
2.36 M
LAST VALUE
-1.78%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR